Italy
Chiesi Group is a leading international biopharmaceuticals company with a focus on respiratory health, rare diseases, and specialty care. Through their innovative therapeutic solutions, the company is dedicated to improving people’s quality of life while prioritizing social and environmental responsibility. Chiesi has transitioned to a Benefit Corporation in Italy, the US, and France, legally binding the commitment to creating shared value for society, and holds B Corp certification since 2019. The company has set an ambitious target to achieve Net-Zero greenhouse gas emissions by 2035.
With over 85 years of experience, Chiesi operates in 31 countries and employs more than 6,500 individuals. The company's main research and development center is located in Parma, Italy, supported by six other key R&D hubs in France, the US, Canada, China, the UK, and Sweden. This extensive global presence underscores Chiesi's commitment to advancing healthcare on a global scale.
For more information, visit www.chiesi.com. In an industry where innovation and societal impact are paramount, Chiesi Group is positioned as a key player, poised for further growth and advancement in the biopharmaceuticals sector.
